KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 147 filers reported holding KARUNA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,480,644 | -23.4% | 44,241 | -1.7% | 0.01% | -14.3% |
| Q2 2023 | $9,763,236 | -33.7% | 45,023 | -44.6% | 0.01% | -41.7% |
| Q1 2023 | $14,731,397 | +5.5% | 81,269 | +14.4% | 0.01% | +9.1% |
| Q4 2022 | $13,958,181 | -9.9% | 71,034 | +3.1% | 0.01% | -21.4% |
| Q3 2022 | $15,500,000 | +47.9% | 68,913 | -16.8% | 0.01% | +55.6% |
| Q2 2022 | $10,483,000 | -36.0% | 82,864 | -35.9% | 0.01% | -18.2% |
| Q1 2022 | $16,391,000 | -3.6% | 129,277 | -0.4% | 0.01% | 0.0% |
| Q4 2021 | $17,007,000 | +8.9% | 129,823 | +1.7% | 0.01% | 0.0% |
| Q3 2021 | $15,618,000 | +7.1% | 127,671 | -0.2% | 0.01% | +10.0% |
| Q2 2021 | $14,580,000 | -11.9% | 127,906 | -7.1% | 0.01% | -16.7% |
| Q1 2021 | $16,545,000 | +16.0% | 137,611 | -2.0% | 0.01% | +9.1% |
| Q4 2020 | $14,261,000 | +39.7% | 140,376 | +6.3% | 0.01% | +22.2% |
| Q3 2020 | $10,209,000 | +16.3% | 132,033 | +67.7% | 0.01% | +12.5% |
| Q2 2020 | $8,777,000 | – | 78,743 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 1,729,352 | $28,223,000 | 2.55% |
| WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST | 1,266,376 | $20,579,000 | 0.33% |
| Rock Springs Capital Management LP | 360,400 | $5,882,000 | 0.23% |
| PFM Health Sciences, LP | 410,643 | $6,702,000 | 0.20% |
| Eventide Asset Management | 296,000 | $4,831,000 | 0.16% |
| Atom Investors LP | 101,205 | $1,652,000 | 0.11% |
| DAFNA Capital Management LLC | 11,192 | $183,000 | 0.07% |
| Maven Securities LTD | 13,080 | $213,000 | 0.07% |
| OXFORD ASSET MANAGEMENT LLP | 100,923 | $1,647,000 | 0.04% |
| Sands Capital Management | 578,895 | $8,277,000 | 0.03% |